moxisylyte has been researched along with Diabetes Mellitus in 2 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sugihara, I | 1 |
| Ishibashi, T | 1 |
| Furutani, S | 1 |
| Kurimoto, S | 1 |
| Turner, RC | 1 |
| Oakley, NW | 1 |
| Nabarro, JD | 1 |
2 other studies available for moxisylyte and Diabetes Mellitus
| Article | Year |
|---|---|
[Acute and chronic effect of moxisylyte hydrochloride on the retinal circulation in diabetes mellitus].
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Diabetes Mellitus; Female; Humans; Male; Middle A | 1991 |
Changes in plasma insulin during ethanol-induced hypoglycemia.
Topics: Adenoma, Islet Cell; Blood Glucose; Diabetes Mellitus; Ethanol; Fasting; Humans; Insulin; Iodine Iso | 1973 |